162 related articles for article (PubMed ID: 36687439)
1. Comparing absorbed doses and radiation risk of the α-emitting bone-seekers [
Lassmann M; Eberlein U
Front Med (Lausanne); 2022; 9():1057373. PubMed ID: 36687439
[TBL] [Abstract][Full Text] [Related]
2. α-Particle-induced DNA damage tracks in peripheral blood mononuclear cells of [
Schumann S; Eberlein U; Lapa C; Müller J; Serfling S; Lassmann M; Scherthan H
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2761-2770. PubMed ID: 33537837
[TBL] [Abstract][Full Text] [Related]
3. Dose estimation after a mixed field exposure: Radium-223 and intensity modulated radiotherapy.
Bastiani I; McMahon SJ; Turner P; Redmond KM; McGarry CK; Cole A; O'Sullivan JM; Prise KM; Ainsbury L; Anderson R
Nucl Med Biol; 2022; 106-107():10-20. PubMed ID: 34968973
[TBL] [Abstract][Full Text] [Related]
4. The impact of age on radium-223 distribution and an evaluation of molecular imaging surrogates.
Jiang W; Ulmert D; Simons BW; Abou DS; Thorek DLJ
Nucl Med Biol; 2018; 62-63():1-8. PubMed ID: 29800797
[TBL] [Abstract][Full Text] [Related]
5. Radiotoxicity of alpha particles versus high and low energy electrons in hypoxic cancer cells.
Maucksch U; Runge R; Oehme L; Kotzerke J; Freudenberg R
Nuklearmedizin; 2018 Apr; 57(2):56-63. PubMed ID: 29590676
[TBL] [Abstract][Full Text] [Related]
6. Micellar solution of [
Pijeira MSO; Gomes-da-Silva NC; Ricci-Junior E; Alencar LMR; İlem-Özdemir D; Cavalcanti ADS; Machado DE; Perini JA; Santos-Oliveira R
Int J Pharm; 2024 Mar; 652():123765. PubMed ID: 38195032
[TBL] [Abstract][Full Text] [Related]
7. Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [223Ra]RaCl2 therapy.
Sraieb M; Hirmas N; Conrad R; Marinova M; Essler M; Herrmann K; Ahmadzadehfar H
Medicine (Baltimore); 2020 Sep; 99(38):e22287. PubMed ID: 32957385
[TBL] [Abstract][Full Text] [Related]
8. S-values for radium-223 and absorbed doses estimates for
Silva CCO; da Silva AX; Braz D; Lima LFC; Segars WP; de Sá LV
Appl Radiat Isot; 2022 Nov; 189():110387. PubMed ID: 36137481
[TBL] [Abstract][Full Text] [Related]
9. [
Yang Y; Alencar LMR; Pijeira MSO; Batista BDS; França ARS; Rates ERD; Lima RC; Gemini-Piperni S; Santos-Oliveira R
Drug Deliv; 2022 Dec; 29(1):186-191. PubMed ID: 35191342
[TBL] [Abstract][Full Text] [Related]
10. Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting (223)Ra-dichloride.
Pacilio M; Ventroni G; De Vincentis G; Cassano B; Pellegrini R; Di Castro E; Frantellizzi V; Follacchio GA; Garkavaya T; Lorenzon L; Ialongo P; Pani R; Mango L
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):21-33. PubMed ID: 26266887
[TBL] [Abstract][Full Text] [Related]
11. Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223.
Caffo O; Frantellizzi V; Tucci M; Galli L; Monari F; Baldari S; Masini C; Bortolus R; Facchini G; Alongi P; Agostini S; Zichi C; Biasco E; Fanti S; Pignata S; Filice A; Borsatti E; Rossetti S; Spada M; Cortesi E; De Vincentis G
Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2633-2638. PubMed ID: 32249345
[TBL] [Abstract][Full Text] [Related]
12. Quantitative measurement of
Ooe K; Watabe T; Kamiya T; Yoshimura T; Hosono M; Shinohara A; Hatazawa J
EJNMMI Phys; 2019 Jul; 6(1):13. PubMed ID: 31350633
[TBL] [Abstract][Full Text] [Related]
13. Intra-articular use of radium dichloride ([
Corrêa LB; de Oliveira Henriques MDGM; Rosas EC; Santos-Oliveira R
Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):336-344. PubMed ID: 34370060
[TBL] [Abstract][Full Text] [Related]
14. Dosimetry of 223Ra-chloride: dose to normal organs and tissues.
Lassmann M; Nosske D
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):207-12. PubMed ID: 23053328
[TBL] [Abstract][Full Text] [Related]
15. Quantitative comparisons of cancer induction in humans by internally deposited radionuclides and external radiation.
Harrison JD; Muirhead CR
Int J Radiat Biol; 2003 Jan; 79(1):1-13. PubMed ID: 12556326
[TBL] [Abstract][Full Text] [Related]
16. Decreasing undesirable absorbed radiation to the intestine after administration of radium-223 dichloride for treatment of bone metastases.
Ogawa K; Higashi T; Mishiro K; Wakabayashi H; Shiba K; Odani A; Kinuya S
Sci Rep; 2020 Jul; 10(1):11917. PubMed ID: 32681007
[TBL] [Abstract][Full Text] [Related]
17. Influence of human biokinetics of strontium on internal ingestion dose of 90Sr and absorbed dose of 89Sr to organs and metastases.
Li WB; Höllriegl V; Roth P; Oeh U
Radiat Environ Biophys; 2008 Apr; 47(2):225-39. PubMed ID: 18204850
[TBL] [Abstract][Full Text] [Related]
18. Radiopharmacokinetic modelling and radiation dose assessment of
Höllriegl V; Petoussi-Henss N; Hürkamp K; Ocampo Ramos JC; Li WB
EJNMMI Phys; 2021 Jun; 8(1):44. PubMed ID: 34076794
[TBL] [Abstract][Full Text] [Related]
19.
Fosbøl MØ; Petersen PM; Kjaer A; Mortensen J
J Nucl Med; 2018 Apr; 59(4):596-602. PubMed ID: 28864632
[TBL] [Abstract][Full Text] [Related]
20. Targeting of osseous sites with alpha-emitting 223Ra: comparison with the beta-emitter 89Sr in mice.
Henriksen G; Fisher DR; Roeske JC; Bruland ØS; Larsen RH
J Nucl Med; 2003 Feb; 44(2):252-9. PubMed ID: 12571218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
